Horizon Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Horizon Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
1.2%
Buyback Yield
| Total Shareholder Yield | 1.2% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
These 4 Measures Indicate That Horizon Therapeutics (NASDAQ:HZNP) Is Using Debt Safely
Nov 25
Do Horizon Therapeutics' (NASDAQ:HZNP) Earnings Warrant Your Attention?
Nov 02Horizon pays HemoShear milestone payment under pact to develop gout therapies
Sep 21Horizon Therapeutics announces $500M buyback program
Sep 09Horizon Therapeutics to expand footprint in Ireland
Aug 29Is Horizon Therapeutics (NASDAQ:HZNP) A Risky Investment?
Aug 22Horizon Therapeutics: This Core Biotech Company Is On Sale
Aug 19Analyst Forecasts Just Became More Bearish On Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)
Aug 04Do Horizon Therapeutics' (NASDAQ:HZNP) Earnings Warrant Your Attention?
Aug 02Horizon Therapeutics: Buy The Dip For Slightly Risky, Catalyst Driven Growth
Jul 31Horizon gets FDA approval for Krystexxa's use with methotrexate for uncontrolled gout
Jul 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if HZNP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HZNP's dividend payments have been increasing.
Dividend Yield vs Market
| Horizon Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HZNP) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (HZNP) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate HZNP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HZNP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate HZNP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HZNP has not reported any payouts.